BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8857740)

  • 1. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration.
    Goto S; Matsumoto S; Ushio Y; Hirano A
    Neurology; 1996 Oct; 47(4):1032-6. PubMed ID: 8857740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin immunoreactivity in striatonigral degeneration.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(1):65-71. PubMed ID: 2544073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhomogeneity of the putaminal lesion in striatonigral degeneration.
    Goto S; Hirano A
    Acta Neuropathol; 1990; 80(2):204-7. PubMed ID: 1975151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
    Ito H; Goto S; Sakamoto S; Hirano A
    Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration.
    Goto S; Hirano A; Matsumoto S
    Neurology; 1990 Jul; 40(7):1051-6. PubMed ID: 2192300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anatomical connections of the basal ganglia].
    Fujiyama F
    Brain Nerve; 2009 Apr; 61(4):341-9. PubMed ID: 19378803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatopallidonigral degeneration in Pick's disease: a clinicopathological study of 41 cases.
    Kosaka K; Ikeda K; Kobayashi K; Mehraein P
    J Neurol; 1991 Jun; 238(3):151-60. PubMed ID: 1869891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic involvement of the striatal efferents in basal ganglia of patients with adult-onset motor neuron disease with basophilic inclusions.
    Ito H; Kusaka H; Matsumoto S; Imai T
    Acta Neuropathol; 1995; 89(6):513-8. PubMed ID: 7545858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efferent connections of the caudate nucleus, including cortical projections of the striatum and other basal ganglia: an autoradiographic and horseradish peroxidase investigation in the cat.
    Royce GJ; Laine EJ
    J Comp Neurol; 1984 Jun; 226(1):28-49. PubMed ID: 6736295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation.
    Wakai M; Kume A; Takahashi A; Ando T; Hashizume Y
    Acta Neurol Scand; 1994 Oct; 90(4):225-31. PubMed ID: 7839806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey.
    Selemon LD; Goldman-Rakic PS
    J Comp Neurol; 1990 Jul; 297(3):359-76. PubMed ID: 1697864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.
    François C; Grabli D; McCairn K; Jan C; Karachi C; Hirsch EC; Féger J; Tremblay L
    Brain; 2004 Sep; 127(Pt 9):2055-70. PubMed ID: 15292054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatonigral degeneration.
    Kan AE
    Pathology; 1978 Jan; 10(1):45-52. PubMed ID: 643319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatonigral degeneration: clinical, MRI, and pathologic correlation.
    O'Brien C; Sung JH; McGeachie RE; Lee MC
    Neurology; 1990 Apr; 40(4):710-1. PubMed ID: 2320250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy.
    Ito H; Kusaka H; Matsumoto S; Imai T
    Neurology; 1996 Nov; 47(5):1291-9. PubMed ID: 8909445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on basal ganglia connections as described by Nauta and Mehler in 1966: Where we were and how this paper effected where we are now.
    Haber S
    Brain Res; 2016 Aug; 1645():4-7. PubMed ID: 27064077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in research on basal ganglia. Introduction].
    Takada M
    Brain Nerve; 2009 Apr; 61(4):338-9. PubMed ID: 19378802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel grading scale for striatonigral degeneration (multiple system atrophy).
    Wenning GK; Seppi K; Tison F; Jellinger K
    J Neural Transm (Vienna); 2002 Mar; 109(3):307-20. PubMed ID: 11956953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.